FDA turns to Fresenius imports from EU to help with common cancer drug shortage
The FDA acknowledged today that it’s been allowing temporary imports of the commonly used cancer drug cisplatin from Fresenius Kabi to help shore up the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
